Gapping down
In reaction to earnings/guidance:
- RDW -16.9%, BLND -16%, DCT -11.4%, BB -4%, WEJO -3.2%, ASTS -1.4%
Other news:
- SLS -22.5% (signs license agreement with GenFleet Therapeutics for GFH009; prices offering of 4629630 shares of its common stock and accompanying warrants to purchase up to 4629630 shares of common stock at a combined public offering price of $5.40 per share and accompanying warrant)
- SPRO -19.5% (FDA identifies deficiencies in Spero's NDA for tebipenem)
- ALE -5.6% (prices offering of 3.2 mln shares of common stock at $63.00 per share)
- IIPR -3.6% (commences public offering of 1 mln shares)
- ATCX -2.1% (stock offering)
Analyst comments:
- AMLX -3.4% (downgraded to Neutral from Buy at Goldman)
- W -2.5% (downgraded to Underweight from Equal Weight at Barclays)
- COMM -2.3% (downgraded to Neutral from Buy at Goldman)
- DELL -0.9% (downgraded to Neutral from Conviction Buy at Goldman)